Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Overman

Showing results (241-250 of 265) with videos related to

Pageof 27
Sort By:
Clinical Colorectal Cancer|November 19, 2021
Benchmarking Outcomes for Definitive Treatment of Young-Onset, Locally Advanced Rectal CancerNicolette Taku, Y Nancy Yi-Qian, George J Chang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 22, 2018
Anti-EGFR-resistant clones decay exponentially after progression: implications for anti-EGFR re-challengeC M Parseghian, J M Loree, V K Morris, et al.
European Journal of Nutrition|July 3, 2016
Evaluation of cognitive subdomains, 25-hydroxyvitamin D, and 1,25-dihydroxyvitamin D in the European Male Ageing StudyMargot J Overman, Neil Pendleton, Terence W O'Neill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2019
Nivolumab Is Effective in Mismatch Repair-Deficient Noncolorectal Cancers: Results From Arm Z1D-A Subprotocol of the NCI-MATCH (EAY131) StudyNilofer S Azad, Robert J Gray, Michael J Overman, et al.
Medrxiv : the Preprint Server for Health Sciences|September 25, 2023
The Clinical Significance of CEA, CA19-9, and CA125 in Management of Appendiceal AdenocarcinomaAbdelrahman Yousef, Mahmoud Yousef, Mohammad Zeineddine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2021
Pilot Clinical Trial of Perioperative Durvalumab and Tremelimumab in the Treatment of Resectable Colorectal Cancer Liver MetastasesPreeti Kanikarla Marie, Cara Haymaker, Edwin Roger Parra, et al.
Molecular Cancer Therapeutics|May 22, 2016
BRAF Mutation Testing in Cell-Free DNA from the Plasma of Patients with Advanced Cancers Using a Rapid, Automated Molecular Diagnostics SystemFilip Janku, Helen J Huang, Bart Claes, et al.
Cancer|January 26, 2018
Imaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography scans indicate response to cytotoxic therapyAhmed M Amer, Mohamed Zaid, Baishali Chaudhury, et al.
JAMA Oncology|September 12, 2024
Molecular, Socioeconomic, and Clinical Factors Affecting Racial and Ethnic Disparities in Colorectal Cancer SurvivalMahmoud Yousef, Abdelrahman Yousef, Saikat Chowdhury, et al.
Journal for Immunotherapy of Cancer|February 10, 2025
Sex and outcomes of patients with microsatellite instability-high and <i>BRAF</i> V600E mutated metastatic colorectal cancer receiving immune checkpoint inhibitorsVincenzo Nasca, Joseph Zhao, Javier Ros, et al.
Pageof 27

Showing results (241-250 of 265) with videos related to

Sort By:
Pageof 27
Clinical Colorectal Cancer|November 19, 2021
Benchmarking Outcomes for Definitive Treatment of Young-Onset, Locally Advanced Rectal CancerNicolette Taku, Y Nancy Yi-Qian, George J Chang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 22, 2018
Anti-EGFR-resistant clones decay exponentially after progression: implications for anti-EGFR re-challengeC M Parseghian, J M Loree, V K Morris, et al.
European Journal of Nutrition|July 3, 2016
Evaluation of cognitive subdomains, 25-hydroxyvitamin D, and 1,25-dihydroxyvitamin D in the European Male Ageing StudyMargot J Overman, Neil Pendleton, Terence W O'Neill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2019
Nivolumab Is Effective in Mismatch Repair-Deficient Noncolorectal Cancers: Results From Arm Z1D-A Subprotocol of the NCI-MATCH (EAY131) StudyNilofer S Azad, Robert J Gray, Michael J Overman, et al.
Medrxiv : the Preprint Server for Health Sciences|September 25, 2023
The Clinical Significance of CEA, CA19-9, and CA125 in Management of Appendiceal AdenocarcinomaAbdelrahman Yousef, Mahmoud Yousef, Mohammad Zeineddine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2021
Pilot Clinical Trial of Perioperative Durvalumab and Tremelimumab in the Treatment of Resectable Colorectal Cancer Liver MetastasesPreeti Kanikarla Marie, Cara Haymaker, Edwin Roger Parra, et al.
Molecular Cancer Therapeutics|May 22, 2016
BRAF Mutation Testing in Cell-Free DNA from the Plasma of Patients with Advanced Cancers Using a Rapid, Automated Molecular Diagnostics SystemFilip Janku, Helen J Huang, Bart Claes, et al.
Cancer|January 26, 2018
Imaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography scans indicate response to cytotoxic therapyAhmed M Amer, Mohamed Zaid, Baishali Chaudhury, et al.
JAMA Oncology|September 12, 2024
Molecular, Socioeconomic, and Clinical Factors Affecting Racial and Ethnic Disparities in Colorectal Cancer SurvivalMahmoud Yousef, Abdelrahman Yousef, Saikat Chowdhury, et al.
Journal for Immunotherapy of Cancer|February 10, 2025
Sex and outcomes of patients with microsatellite instability-high and <i>BRAF</i> V600E mutated metastatic colorectal cancer receiving immune checkpoint inhibitorsVincenzo Nasca, Joseph Zhao, Javier Ros, et al.
Pageof 27